HKD 0.93
(1.09%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 74.18 Million CNY | 67.47% |
2022 | 45.61 Million CNY | -36.33% |
2021 | 71.64 Million CNY | -35.64% |
2020 | 111.31 Million CNY | 80.73% |
2019 | 61.59 Million CNY | 21.59% |
2018 | 50.65 Million CNY | -13.66% |
2017 | 58.67 Million CNY | 15.94% |
2016 | 50.6 Million CNY | -11.82% |
2015 | 57.38 Million CNY | 44.21% |
2014 | 39.79 Million CNY | 19.51% |
2013 | 33.29 Million CNY | 11.91% |
2012 | 29.75 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 10.42 Million CNY | 0.0% |
2023 Q4 | 49.92 Million CNY | 0.0% |
2023 Q2 | 24.14 Million CNY | 0.0% |
2023 FY | 76.38 Million CNY | 67.47% |
2022 FY | 45.61 Million CNY | -36.33% |
2022 Q2 | 2.67 Million CNY | 0.0% |
2022 Q4 | 42.94 Million CNY | 0.0% |
2021 Q2 | 45.93 Million CNY | 0.0% |
2021 Q4 | 25.7 Million CNY | 0.0% |
2021 FY | 71.64 Million CNY | -35.64% |
2020 Q4 | 75.88 Million CNY | 0.0% |
2020 FY | 111.31 Million CNY | 80.73% |
2020 Q2 | 35.43 Million CNY | 0.0% |
2019 Q2 | 31.18 Million CNY | 0.0% |
2019 FY | 61.59 Million CNY | 21.59% |
2019 Q4 | 30.41 Million CNY | 0.0% |
2018 Q4 | 28.92 Million CNY | 0.0% |
2018 FY | 50.65 Million CNY | -13.66% |
2018 Q2 | 21.73 Million CNY | 0.0% |
2017 FY | 58.67 Million CNY | 15.94% |
2017 Q4 | 30.85 Million CNY | 0.0% |
2017 Q2 | 27.81 Million CNY | 0.0% |
2016 Q4 | 29.22 Million CNY | 0.0% |
2016 FY | 50.6 Million CNY | -11.82% |
2016 Q2 | 21.38 Million CNY | 0.0% |
2015 Q2 | 37.58 Million CNY | 0.0% |
2015 FY | 57.38 Million CNY | 44.21% |
2015 Q4 | 19.8 Million CNY | 0.0% |
2014 Q4 | 27.67 Million CNY | 0.0% |
2014 Q2 | 12.11 Million CNY | 0.0% |
2014 FY | 39.79 Million CNY | 19.51% |
2013 Q2 | 11.89 Million CNY | 0.0% |
2013 Q4 | 21.4 Million CNY | 0.0% |
2013 FY | 33.29 Million CNY | 11.91% |
2012 Q1 | 7.43 Million CNY | 0.0% |
2012 Q2 | 7.43 Million CNY | 0.0% |
2012 Q3 | 7.43 Million CNY | 0.0% |
2012 Q4 | 8.22 Million CNY | 10.63% |
2012 FY | 29.75 Million CNY | 0.0% |
2011 Q4 | 7.43 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Natural Beauty Bio-Technology Limited | 204.08 Million HKD | 63.648% |
Innovative Pharmaceutical Biotech Limited | 14.27 Million HKD | -419.749% |
China Overseas Nuoxin International Holdings Limited | 38.32 Million HKD | -93.569% |
Prosperous Future Holdings Limited | 118.15 Million HKD | 37.208% |
Huasheng International Holding Limited | 153.46 Million HKD | 51.657% |
Fourace Industries Group Holdings Limited | 57.65 Million HKD | -28.675% |
Evergreen Products Group Limited | 152.17 Million HKD | 51.246% |
EC Healthcare | 597.44 Million HKD | 87.582% |
Ming Fai International Holdings Limited | 357.68 Million HKD | 79.258% |
Blue Moon Group Holdings Limited | 4.4 Billion HKD | 98.318% |
SuperRobotics Holdings Limited | 15.16 Million HKD | -389.341% |
Takbo Group Holdings Limited | 65.71 Million HKD | -12.89% |
Hyfusin Group Holdings Limited | 196.91 Million HKD | 62.323% |